TCRX - TScan Therapeutics GAAP EPS of -$0.21 revenue of $7.2M March, 06 2024 09:57 AM TScan Therapeutics Inc. 2024-03-06 09:57:47 ET More on TScan Therapeutics TScan: Two 2024 TCR-T Data Readouts Could Bring Significant Value Seeking Alpha’s Quant Rating on TScan Therapeutics Historical earnings data for TScan Therapeutics Financial information for TScan Therapeutics For further details see: TScan Therapeutics GAAP EPS of -$0.21, revenue of $7.2M